Here, we utilized a novel designed peptide (PLPECD, an 83-mer that incorporates the extracellular sequences of PLP while excluding positions buried within or just proximal to transmembrane regions) to test B cell-dependency in the context of PLP-induced demyelinating disease in B6 mice. Here, PLP1 is linked to demyelinating disease.